Table.

Patients’ demographic information, and the features of extracorporeal cardiopulmonary resuscitation.

Patients	F/M	Age (months)	Weight(kg)	Primary diagnosesOperation/procedure	Procedure	The cause of cardiac arrest	Place of cannulation	The site of cannulas	Low-flow time (min)	Survived
1	F	144	40	Type 1 hyperlipidemiaAortic valve stenosis	AVR	Arrhythmia	PICU	FV-FA	70	Yes
2	F	132	145	S-CMP	None	Sepsis	PICU	Not able to be placed	145	No
3	M	60	20	RCMP,	Heart Tx	Bleeding	PICU	FV-FA	100	No
4	F	96	18	DCMP,	Heart Tx	Arrhythmia	PICU	FV-FA	20	Yes
5	F	4	4.8	AVSD	TC	LCOS	OR	Central	45	No
6	M	8	6	TAPVR, ASD, dextrocardia	None	Hypoxemia	OR	IJV-CA	110	No
7	F	42	12	Hydroxyflouric acid poisoning	None	Malignant arrhythmias	PICU	FV-FA	120	No
8	M	156	40	Lighter gas inhalation(poisoning)	None	Malignant arrhythmias	PICU	Not able to placed	105	No
9	M	24	10	ARDS, septic shock	None	Sepsis	OR	Not able tobe placed	120	No
10	F	23	12	Fulminant myocarditis	None	Cardiac failure	OR	IJV- CA	320	No
11	M	156	30	Danon disease	None	Arrhythmia	PICU	FV-FA	45	No
12	M	156	54	DCMP	Heart Tx	Cardiac failure	PICU	FV-FA	60	Yes
13	M	132	22	ARVD/C	None	Arrhythmia	OR	FV-FA	45	Yes
14	F	12	7	CoA, PDA ligation	TC	Arrhythmia	OR	IJV-CA	90	No
15	F	5	6	ASD and VSD	TC	LCOS	OR	Central	120	Yes

F/M, female/male; ECPR, extracorporeal membrane oxygenation; PC, postcardiotomy; S-CMP, sepsis-related cardiomyopathy; RCMP, restrictive cardiomyopathy; DCMP, dilated cardiomyopathy; AVR, aortic valve replacement; FV, femoral vein; FA, femoral artery; M, male; F, female; OR, operating room; TAPVR, total anomalous pulmonary venous return; AVSD, atrioventricular septal defect; PDA, patent ductus arteriosus; ASD, atrial septal defect; VSD, ventricular septal defect; TC, total correction; ARVD/C, arrhythmogenic right ventricular dysplasia/cardiomyopathy; CoA, coarctation of aorta; LCOS, low cardiac output state; IJV, internal jugular vein; CA, carotid artery; heart Tx, heart transplantation.